3858 results for «2380»
3858 results
AICT-AsiaPCR 2022 Closing Ceremony
08 Oct 2022 – From AICT-AsiaPCR 2022
In this Closing Ceremony, Ashok Seth thanks all participants, Programme Committee Members, Faculty members and presenters, LIVE operating teams and Industry Partners for being part of this fantastic online and onsite edition of AICT-AsiaPCR 2022, while he highlights the key moments of the course.
A case-based tailored approach to the treatment of mitral valve disease: the Heart Team ring
28 Nov 2022 – From PCR London Valves 2022
Join an advanced Heart Team in a real case discussion to understand what "mitral valve complexity" really means and to learn how to optimise selection between repair and replacement options.
Haemodynamic performance of transcatheter aortic valves: practical considerations for lifetime management
28 Nov 2022 – From PCR London Valves 2022
Watch this highly interactive session which focuses on the impact of haemodynamic performance on valve durability and patient survival, and how the design of bioprosthetic aortic valves influences clinical outcomes.
Tricuspid valve intervention - Get it right!
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to learn tips and tricks that influence procedural strategy through a real-life case as well as anatomical factors that contribute to tricuspid valve complexity and choice of treatment, followed by the latest clinical data.
Maintaining selective coronary access after TAVI and re-do TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to understand the various challenges when trying to get coronary access after TAVI, learn different techniques and discuss the options for coronary access after re-do TAVI.
Optimising immediate and long-term outcomes after TAVI
29 Nov 2022 – From PCR London Valves 2022
This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.
The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems
27 Nov 2022 – From PCR London Valves 2022
In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.
Therapy of valvular heart diseases: a patient-centred innovation journey
27 Nov 2022 – From PCR London Valves 2022
Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.
Rapid-fire clinical cases: session 2
27 Nov 2022 – From PCR London Valves 2022
Discover in the same PCR LV 2022 session a TAVI for pure aortic regurgitation in degenerated aortic homograft, an embolised Myval transcatheter heart valve to AAA, or a challenging ViV TAVI, and much more!
Valve-in-valve interventions
27 Nov 2022 – From PCR London Valves 2022
The 8 videos in this PCR LV 2022 session on ViV procedures will allow you to learn more about ultrasound imaging for BASILICA procedure optimization in ViV TAVI, or compare coronary access between 2 self-expandable TAVI in degenerated surgical bioprosthesis, and much more!
Valve-in-valve TAVI: session 1
27 Nov 2022 – From PCR London Valves 2022
ViV TAVI in a patient with previous Bentall's operation, ViV for a failed surgical aortic bioprosthesis with a misaligned mitral bioprosthesis, TAVI for severe aortic regurgitation caused by infective endocarditis after homograft surgery, and much more in this PCR LV 2022 session about ViV TAVI!
Ensuring optimal TAVI outcomes - LIVE case
27 Nov 2022 – From PCR London Valves 2022
A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...
Rapid-fire abstracts: session 1
27 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!
Repair vs. replacement for the treatment of tricuspid valve disease
27 Nov 2022 – From PCR London Valves 2022
Watch this session on tricuspid valve disease to learn more about its current modes of treatment (including new and emerging devices), to understand which patients are the best candidates for this procedure and to explore the challenges that may be encountered during it.
Rapid-fire clinical cases: Session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 case submissions in this session: quadricuspid aortic valve with pure regurgitation treated with Evolut PRO, complex high-risk patient with severe aortic regurgitation and extra-large anatomy, snare-assisted TAVI in case of calcified sinotubular junction, and more!
TAVI: emerging evidence
27 Nov 2022 – From PCR London Valves 2022
Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and...
Rapid-fire abstracts: session 2
27 Nov 2022 – From PCR London Valves 2022
Take advantage of this PCR LV 2022 session to discover more abstracts and learn more about how to predict TAVI bicuspid aortic valve re-access, or right ventricle-pulmonary artery coupling in patients with severe aortic stenosis, among others.
TAVI challenges: session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.
CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.
Primary mitral regurgitation: treatment options when the anatomy is simple
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn about the different technical aspects and limitations for both surgical and catheter-based techniques and to understand the design and implications of two current RCTs comparing interventional and surgical techniques in patients with primary mitral regurgitation.
